Oculus Receives FDA Clearance for Pentacam AXL Wave

Oculus announced that the Oculus Pentacam AXL Wave has received FDA 510(k) clearance.

The Pentacam AXL Wave is the latest and most versatile member of the Pentacam family, incorporating intuitive reports based on clinical studies, with network compatibility and full operability of all Pentacam software and examinations, according to a company news release.

The established functions of anterior segment tomography and optical biometry have been complemented by retroillumination and a Hartman-Shack sensor for total eye wavefront and objective refraction. A new examination routine guides the user through the imaging process. The measuring process is straightforward, user-independent, fast and patient-friendly. The intuitive guide allows both eyes to be examined in less than 5 minutes, according to Oculus.

These new hardware and software features allow optical performance analysis of the total cornea, total eye, and crystalline lens or implanted IOL. In addition, the new Pentacam AXL Wave comes with a comprehensive arranged overview display showing all parameters for corneal screening, IOL power selection, IOL power calculation, ICL selection and calculation, and pupil diameter under dimmed and dark conditions.

The standard software package with the IOL calculator and its built-in IOL database provides verification of findings in numerous clinical applications such as corneal refractive surgery, lens refractive surgery, presbyopia solutions, and standard cataract surgery.

Contact your local distributor for more information or visit www.pentacam.com/axl-wave